The fall of the blockbuster drug is forcing life sciences companies to reconsider how they do research and development (R&D).

Life Sciences leaders weigh in on what the future may hold:

  • The importance of flexibility and collaboration
  • How labs help win the war for top-tier talent
  • The growth of computational space